פמוזול

Страна: Израел

Език: иврит

Източник: Ministry of Health

Активна съставка:

LETROZOLE 2.5 MG

Предлага се от:

PERRIGO ISRAEL AGENCIES LTD

АТС код:

L02BG04

Лекарствена форма:

FILM COATED TABLETS

Начин на приложение:

PER OS

Произведено от:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Терапевтична група:

LETROZOLE

Терапевтични показания:

• Femozol (letrozole tablets) is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer . • Femozol is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy .• Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy .• Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer .

Дата Оторизация:

2010-11-01